ID16413A - Pemakaian antagonis bradykinin untuk produksi bahan farmasi guna pengobatan gangguan liver fibrogenetik kronis dan gangguan liver akut - Google Patents

Pemakaian antagonis bradykinin untuk produksi bahan farmasi guna pengobatan gangguan liver fibrogenetik kronis dan gangguan liver akut

Info

Publication number
ID16413A
ID16413A IDP971032A ID971032A ID16413A ID 16413 A ID16413 A ID 16413A ID P971032 A IDP971032 A ID P971032A ID 971032 A ID971032 A ID 971032A ID 16413 A ID16413 A ID 16413A
Authority
ID
Indonesia
Prior art keywords
liver disorders
treatment
production
bradykinin antagonists
pharmaceutical materials
Prior art date
Application number
IDP971032A
Other languages
English (en)
Indonesian (id)
Inventor
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Klaus Wirth
Max Hropot
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID16413A publication Critical patent/ID16413A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP971032A 1996-03-27 1997-03-27 Pemakaian antagonis bradykinin untuk produksi bahan farmasi guna pengobatan gangguan liver fibrogenetik kronis dan gangguan liver akut ID16413A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Publications (1)

Publication Number Publication Date
ID16413A true ID16413A (id) 1997-09-25

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971032A ID16413A (id) 1996-03-27 1997-03-27 Pemakaian antagonis bradykinin untuk produksi bahan farmasi guna pengobatan gangguan liver fibrogenetik kronis dan gangguan liver akut

Country Status (24)

Country Link
US (1) US5863901A (es)
EP (1) EP0797997B1 (es)
JP (1) JP4185169B2 (es)
KR (1) KR100453394B1 (es)
CN (1) CN1164421A (es)
AT (1) ATE297749T1 (es)
AU (1) AU1651697A (es)
BR (1) BR9701455A (es)
CA (1) CA2200040A1 (es)
CZ (1) CZ90797A3 (es)
DE (2) DE19612067A1 (es)
DK (1) DK0797997T3 (es)
ES (1) ES2242973T3 (es)
HR (1) HRP970171A2 (es)
HU (1) HUP9700642A3 (es)
ID (1) ID16413A (es)
IL (1) IL120521A0 (es)
NO (1) NO971453L (es)
PL (1) PL319193A1 (es)
PT (1) PT797997E (es)
SI (1) SI0797997T1 (es)
SK (1) SK39297A3 (es)
TR (1) TR199700228A2 (es)
ZA (1) ZA972599B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
CN102159211A (zh) * 2008-06-20 2011-08-17 金尼医疗公司 用于治疗纤维化疾病或病症的组合物
IL274883B2 (en) 2017-11-24 2023-11-01 Pharvaris Netherlands B V BRADYKININ B2 receptor antagonists
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
AU3428089A (en) * 1988-03-25 1989-10-16 The Administrators Of The Tulane Eductional Fund Therapeutic peptides
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
CZ203693A3 (en) * 1991-04-01 1994-07-13 Cortech Bradykinin antagonists
WO1992018156A1 (en) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Bradykinin antagonist peptides
ES2123556T3 (es) * 1991-04-19 1999-01-16 Scios Nova Inc Peptidos de tipo bradiquinina.
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (es) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU5098593A (en) * 1992-09-11 1994-04-12 Lajos Gera Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
CA2171446C (en) * 1993-09-09 2004-11-23 Donald James Kyle Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
CA2184824A1 (en) * 1994-03-09 1995-09-14 Val S. Goodfellow Bradykinin antagonist peptides incorporating n-substituted glycines

Also Published As

Publication number Publication date
KR100453394B1 (ko) 2004-12-30
PL319193A1 (en) 1997-09-29
JPH1017491A (ja) 1998-01-20
CZ90797A3 (en) 1997-10-15
NO971453D0 (no) 1997-03-26
HRP970171A2 (en) 1998-04-30
PT797997E (pt) 2005-09-30
MX9702292A (es) 1997-09-30
BR9701455A (pt) 1998-08-18
ATE297749T1 (de) 2005-07-15
KR970064622A (ko) 1997-10-13
EP0797997A3 (de) 2000-05-31
DE59712344D1 (de) 2005-07-21
EP0797997A2 (de) 1997-10-01
ZA972599B (en) 1997-09-29
DE19612067A1 (de) 1997-10-02
TR199700228A2 (xx) 1997-10-21
NO971453L (no) 1997-09-29
ES2242973T3 (es) 2005-11-16
SI0797997T1 (en) 2005-10-31
CN1164421A (zh) 1997-11-12
SK39297A3 (en) 1997-10-08
HUP9700642A3 (en) 1998-03-02
HUP9700642A2 (hu) 1998-01-28
CA2200040A1 (en) 1997-09-27
US5863901A (en) 1999-01-26
AU1651697A (en) 1997-10-02
IL120521A0 (en) 1997-07-13
DK0797997T3 (da) 2005-10-17
HU9700642D0 (en) 1997-05-28
JP4185169B2 (ja) 2008-11-26
EP0797997B1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
NO911854D0 (no) Fremgangsmaate for fremstilling av peptid-derivater.
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
DE69621799D1 (de) Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen
NO972311L (no) Anvendelse av ikke-peptidiske Bradykinin-antagonister for behandling og prevensjon av kronisk fibrogenetiske leversykdommer, akutte leversykdommer og de dermed forbundne komplikasjoner
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
IL120521A0 (en) Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
ATE170076T1 (de) Angiotensin ii-antagonisten zur behandlung von viralen erkrankungen
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
NO994630L (no) Metoder for behandling av vaskulaere sykdommer
DE69223455D1 (de) WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
HU9403783D0 (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
AU4016189A (en) Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
EA200200559A1 (ru) Способ лечения и профилактики нейродегенеративных состояний
ATE242766T1 (de) Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen
UA23301A (uk) Спосіб приготуваhhя ембіхіhу для іh'єкцій
RU93049605A (ru) Новые гетероциклические соединения, способ их получения, фармацевтическая композиция, способ лечения
RU95110268A (ru) Способ лечения хронических заболеваний гомеопатическими средствами